CONCEPTUS GEARING UP FOR DOMESTIC SALES OF TRANSCERVICAL ACCESS SYSTEM
This article was originally published in The Gray Sheet
Executive Summary
CONCEPTUS GEARING UP FOR DOMESTIC SALES OF TRANSCERVICAL ACCESS SYSTEM pending clearance by FDA of 510(k) applications for the catheters and guidewires that make up the system. The company submitted 510(k)s for the intrauterine infusion devices, which can be used to help diagnose female infertility and related disorders, between May and August of 1993. Conceptus currently is "in the process of hiring a sales force to be ready for the introduction of these products at the end of August," stated Kathryn Tunstall, company president and CEO, at a May 9 session of the Alex. Brown & Sons health care seminar in Baltimore.